These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 1541958

  • 1. A clinical trial of oat bran and niacin in the treatment of hyperlipidemia.
    Keenan JM, Wenz JB, Ripsin CM, Huang Z, McCaffrey DJ.
    J Fam Pract; 1992 Mar; 34(3):313-9. PubMed ID: 1541958
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
    Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM.
    Am J Cardiol; 2010 Feb 15; 105(4):487-94. PubMed ID: 20152243
    [Abstract] [Full Text] [Related]

  • 3. Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects.
    Keenan JM, Wenz JB, Myers S, Ripsin C, Huang ZQ.
    J Fam Pract; 1991 Dec 15; 33(6):600-8. PubMed ID: 1660530
    [Abstract] [Full Text] [Related]

  • 4. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.
    J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099
    [Abstract] [Full Text] [Related]

  • 5. Wax-matrix extended-release niacin vs inositol hexanicotinate: a comparison of wax-matrix, extended-release niacin to inositol hexanicotinate "no-flush" niacin in persons with mild to moderate dyslipidemia.
    Keenan JM.
    J Clin Lipidol; 2013 Apr 22; 7(1):14-23. PubMed ID: 23351578
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp RH, Tun P, Zupkis RV, Greguski RA.
    Arch Intern Med; 1994 Jul 25; 154(14):1586-95. PubMed ID: 8031206
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K.
    Indian Heart J; 2008 Jul 25; 60(3):215-22. PubMed ID: 19240310
    [Abstract] [Full Text] [Related]

  • 8. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study.
    Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT.
    J Am Diet Assoc; 1996 Dec 25; 96(12):1254-61. PubMed ID: 8948386
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with low-dose lovastatin and niacin is as effective as higher-dose lovastatin.
    Gardner SF, Schneider EF, Granberry MC, Carter IR.
    Pharmacotherapy; 1996 Dec 25; 16(3):419-23. PubMed ID: 8726600
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.
    Insull W, McGovern ME, Schrott H, Thompson P, Crouse JR, Zieve F, Corbelli J.
    Arch Intern Med; 2004 May 24; 164(10):1121-7. PubMed ID: 15159270
    [Abstract] [Full Text] [Related]

  • 11. Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
    Demark-Wahnefried W, Bowering J, Cohen PS.
    J Am Diet Assoc; 1990 Feb 24; 90(2):223-9. PubMed ID: 2154513
    [Abstract] [Full Text] [Related]

  • 12. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R, Williams RX, Guha-Ray DK, Sawyers WG, Braun SL, Rains KT.
    Clin Ther; 2006 Jan 24; 28(1):45-54. PubMed ID: 16490579
    [Abstract] [Full Text] [Related]

  • 13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 24; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 14. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.
    Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P, Collins MW.
    Eur J Clin Nutr; 1994 Jul 24; 48(7):465-74. PubMed ID: 7956987
    [Abstract] [Full Text] [Related]

  • 15. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 24; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 16. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 24; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 17. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Dec 24; 435():1-288. PubMed ID: 12595928
    [Abstract] [Full Text] [Related]

  • 18. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 19. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).
    Zhao XQ, Morse JS, Dowdy AA, Heise N, DeAngelis D, Frohlich J, Chait A, Albers JJ, Brown BG.
    Am J Cardiol; 2004 Feb 01; 93(3):307-12. PubMed ID: 14759379
    [Abstract] [Full Text] [Related]

  • 20. Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
    Maccubbin D, Bays HE, Olsson AG, Elinoff V, Elis A, Mitchel Y, Sirah W, Betteridge A, Reyes R, Yu Q, Kuznetsova O, Sisk CM, Pasternak RC, Paolini JF.
    Int J Clin Pract; 2008 Dec 01; 62(12):1959-70. PubMed ID: 19166443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.